[The ototoxicity of cisplatin in the chemotherapy of tumors of the head-neck area. Our experience].
The literature reports conflicting results on ototoxicity, one of the best known adverse effects of cis-platinum. An audiometric study was therefore performed in patients treated with this drug for tumours of the head and neck. The possible hearing loss does not rule out the use of cis-platinum in our experience.
Sbalzarini
G
G
I Divisione Medica, U.S.S.L. n. 56, Lodi.
Malusardi
G
G
Pandolfi
C
C
Cerri
A
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects*; D005260:Female; D006258:Head and Neck Neoplasms / Q000150:complications / Q000188:drug therapy*; D006309:Hearing / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000150:complications / Q000188:drug therapy*
D002945:Cisplatin
Ototossicità del cisplatino nella chemioterapia dei tumori del distretto testa-collo. Nostra esperienza.